| CLASS | DRUG/TOX | LP7790-1 |
| COMPONENT | 2-Oxo-3-Hydroxy-Lysergate diethylamide | LP36883-4 |
| PROPERTY | PrThr | LP217195-9 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Urine | LP7681-2 |
| SCALE_TYP | Ord | LP7751-3 |
| METHOD_TYP | Confirm | LP6197-0 |
| parent | 2-Oxo-3-Hydroxy-Lysergate diethylamide | Urine | Drug toxicology | LP389758-6 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Both | |
| UNITSREQUIRED | N | |
| STATUS | ACTIVE |
| LONG_COMMON_NAME | en-US | 2-Oxo-3-Hydroxy-Lysergate diethylamide [Presence] in Urine by Confirmatory method |
| LONG_COMMON_NAME | en-US | 2-Oxo-3-Hydroxy-Lysergate diethylamide [Presence] in Urine by Confirmatory method |
| SHORTNAME | en-US | 2-oxo-3-OH-LDS Ur Ql Cfm |
| ConsumerName | en-US | 2-Oxo-3-Hydroxy-Lysergate diethylamide, Urine |
| LONG_COMMON_NAME | fr-FR | 2-oxo-3-hydroxy lysergate diéthylamide [Présence/Seuil] Urine ; Qualitatif ; Confirmation |
| LONG_COMMON_NAME | nl-NL | 2-oxo-3-hydroxy-lysergatedi-ethylamide [aanwezigheid] in urine d.m.v. bevestiging |
LOINC Version: 2.81
FHIR